======= TRAPPC2L ======= == Gene Information == * **Official Symbol**: TRAPPC2L * **Official Name**: trafficking protein particle complex 2 like * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51693|51693]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UL33|Q9UL33]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TRAPPC2L&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TRAPPC2L|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610970|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May play a role in vesicular transport from endoplasmic reticulum to Golgi. {ECO:0000269|PubMed:19416478}. |Sybindin| |Sedlin N| |TRAPP complex| |vesicle targeting, rough ER to cis-Golgi| |COPII vesicle coating| |vesicle coating| |COPII-coated vesicle budding| |vesicle targeting, to, from or within Golgi| |Golgi vesicle budding| |vesicle targeting| |vesicle budding from membrane| |establishment of vesicle localization| |vesicle localization| |endoplasmic reticulum to Golgi vesicle-mediated transport| |vesicle organization| |establishment of organelle localization| |Golgi vesicle transport| |protein complex oligomerization| |organelle localization| |Golgi membrane| |intracellular membrane-bounded organelle| |perinuclear region of cytoplasm| |membrane organization| |endoplasmic reticulum| |intracellular transport| |protein-containing complex assembly| |establishment of localization in cell| |protein-containing complex subunit organization| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|-2.27| |[[:results:exp539|42°C R08 exp539]]|-2.25| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|-2.14| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|-1.93| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|-1.91| |[[:results:exp303|39°C R06 exp303]]|-1.7| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|1.72| |[[:results:exp493|IL-3 9ng/ml R08 exp493]]|1.72| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|1.75| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|1.8| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|1.8| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|1.81| |[[:results:exp347|Cyclosporin-A 0.8μM R07 exp347]]|1.81| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|1.82| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.89| |[[:results:exp10|CCCP 0.1μM R00 exp10]]|1.89| |[[:results:exp247|UM0130462 0.025 to 0.035μM day4 R05 exp247]]|1.97| |[[:results:exp183|IU1-C 25μM R04 exp183]]|2| |[[:results:exp232|Epothilone-D 0.004 to 0.006μM on day4 R05 exp232]]|2.08| |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|2.11| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|2.19| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|2.23| |[[:results:exp27|Pimelic-diphenylamide-106 0.5μM R00 exp27]]|2.24| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|2.25| |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|2.26| |[[:results:exp31|Rifampicin 1μM R00 exp31]]|2.29| |[[:results:exp11|CCCP 1μM R00 exp11]]|2.6| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|2.66| ^Gene^Correlation^ |[[:human genes:d:dync1i2|DYNC1I2]]|0.452| |[[:human genes:v:vps54|VPS54]]|0.438| |[[:human genes:n:napa|NAPA]]|0.436| |[[:human genes:t:trappc11|TRAPPC11]]|0.435| |[[:human genes:c:cmya5|CMYA5]]|0.41| |[[:human genes:c:copg1|COPG1]]|0.407| Global Fraction of Cell Lines Where Essential: 2/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|1/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|1/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2222 * **Expression level (log2 read counts)**: 5.09 {{:chemogenomics:nalm6 dist.png?nolink |}}